Lenograstim is a recombinant granulocyte colony-stimulating factor used as an immunostimulating agent.
The drug is used to reduce the risk of life-threatening infection in patients with neutropenia, particularly after cytotoxic chemotherapy.
...
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.